Geographic diversity among genotypes of Entamoeba histolytica field isolates

Journal of Clinical Microbiology

Volumn 41, Issue 8, 2003, Pages 3748-3756

  Haghighi, Ali ^a,d   Kobayashi, Seiki ^b   Takeuchi, Tsutomu ^b   Thammapalerd, Nitaya ^e   Nozaki, Tomoyoshi ^a,c  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CHITINASE; PROTEIN SREHP; PROTOZOAL PROTEIN; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; BANGLADESH; CLINICAL FEATURE; COLITIS; DYSENTERY; ENTAMOEBA HISTOLYTICA; GENE LOCUS; GENE STRUCTURE; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HOST; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAPAN; LIVER ABSCESS; MOLECULAR TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; THAILAND;

AMINO ACID SEQUENCE; ANIMALS; BANGLADESH; BASE SEQUENCE; CAMBODIA; CHITINASE; ENTAMOEBA HISTOLYTICA; GEOGRAPHY; GHANA; HETEROZYGOTE; HUMANS; INDONESIA; JAPAN; MEMBRANE PROTEINS; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTOZOAN PROTEINS; RESTRICTION MAPPING; THAILAND; VARIATION (GENETICS);

ENTAMOEBA; ENTAMOEBA HISTOLYTICA; HUMAN IMMUNODEFICIENCY VIRUS; PROTOZOA;

EID: 0042023333     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.8.3748-3756.2003     Document Type: Article

References (46)

1. Ankri, S., F. Padilla-Vaca, T. Stolarsky, L. Koole, U. Katz, and D. Mirelman. 1999. Antisense inhibition of the light subunit (35 kDa) of the Gal/GalNac lectin complex inhibits Entamoeba histolytica virulence. Mol. Microbiol. 33: 327-337.
2. Ayeh-Kumi, P. F., I. M. Ali, L. A. Lockhart, C. A. Gilchrist, W. A. Petri, Jr., and R. Hague. 2001. Entamoeba histolytica: genetic diversity of clinical isolates from Bangladesh as demonstrated by polymorphisms in the serine-rich gene. Exp. Parasitol. 99:80-88.
3. Blessmann, J., L. P. Van, P. A. Nu, H. D. Thi, B. Muller-Myhsok, H. Buss, and E. Tannich. 2002. Epidemiology of amebiasis in a region of high incidence of amebic liver abscess in central Vietnam. Am. J. Trop. Med. Hyg. 66:578-583.
4. Bruberg, M. B., I. F. Nes, and V. G. Eijsink. 1996. Comparison studies of chitinases A and B from Serratia marcescens. Microbiology 142:1581-1589.
5. Cassol, S., B. G. Weniger, P. G. Babu, M. O. Salminen, X. Zheng, M. T. Htoon, A. Delaney, M. O'Shaughnessy, and C. Y. Ou. 1996. Detection of HIV type 1 env subtypes A, B, C, and E in Asia using dried blood spots: a new surveillance tool for molecular epidemiology. AIDS Res. Hum. Retrovir. 10:1435-1441.
6. Clark, C. G. 2000. The evolution of Entamoeba, a cautionary tale. Res. Microbiol. 151:599-603.
7. Clark, C. G., and L. S. Diamond. 1993. Entamoeba histolytica: a method for isolate identification. Exp. Parasitol. 77:450-455.
8. Diamond, L. S. 1995. Cryopreservation and storage of parasitic protozoa in liquid nitrogen. J. Eukaryot. Microbiol. 42:585-590.
9. Diamond, L. S., D. R. Harlow, and C. C. Cunnick. 1978. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans. R. Soc. Trop. Med. Hyg. 72:431-432.
10. Flores-Romo, L., T. Estrada-Garcia, M. Shibayama-Salas, R. Campos-Rodriguez, K. Bacon, A. Martinez-Palomo, and V. Tsutsumi. 1997. In vitro Entamoeba histolytica adhesion to human endothelium: a comparison using two strains of different virulence. Parasitol. Res. 83:397-400.
11. Gathiram, V., and T. F. H. G. Jackson. 1985. Frequency distribution of Entamoeba histolytica zymodemes in rural South Africa population. Lancet i:719-721.
12. Gathiram, V., and T. F. H. G. Jackson. 1987. A longitudinal study of asymptomatic carriers of pathogenic zymodemes of Entamoeba histolytica. S. Afr. Med. J. 72:669-672.
13. Ghosh, S., M. Frisardi, L. Ramirez-Avila, S. Descoteaux, K. Sturm-Ramirez, O. A. Newton-Sanchez, J. I. Santos-Preciado, C. Ganguly, A. Lohia, S. Reed, and J. Samuelson. 2000. Molecular epidemiology of Entamoeba spp.: evidence of a bottleneck (demographic sweep) and transcontinental spread of diploid parasites. J. Clin. Microbiol. 38:3815-3821.
14. Haghighi, A., S. Kobayashi, T. Takeuchi, G. Masuda, and T. Nozaki. 2002. Remarkable genetic polymorphism among Entamoeba histolytica isolates from a limited geographic area. J. Clin. Microbiol. 40:4081-4090.
15. Haque, R., I. M. Ali, and W. A. Petri, Jr. 1999. Prevalence and immune response to Entamoeba histolytica infection in preschool children in Bangladesh. Am. J. Trop. Med. Hyg. 60:1031-1034.
16. Haque, R., I. M. Ali, R. B. Sack, B. M. Farr, G. Ramakrishnan, and W. A. Petri, Jr. 2001. Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. J. Infect. Dis. 183:1787-1793.
17. Haque, R., P. Duggal, I. M. Ali, M. B. Hossain, D. Monda, R. B. Sack, B. M. Farr, T. H. Beaty, and W. A. Petri, Jr. 2002. Innate and acquired resistance to amebiasis in Bangladeshi children. J. Infect. Dis. 186:547-552.
18. Jackson, T. F. H. G., V. Gathiram, and A. E. Simjee. 1985. Seroepidemiological study of antibody responses to the zymodemes of Entamoeba histolytica. Lancet i:716-719.
19. Joshi, M., A. S. Chowdhary, P. J. Dalal, and J. K. Maniar. 2002. Parasitic diarrhoea in patients with AIDS. Natl. Med. J. India 15:72-74.
20. Kihara, M. 1993. On the recent abrupt rise in the number of foreign females in the AIDS surveillance in Japan. Nippon Koshu Eisei Zasshi 40:1001-1005.
21. Law, C. L., J. Walker, and M. H. Qassim. 1991. Factors associated with the detection of Entamoeba histolytica in homosexual men. Int. J. STD AIDS 2:346-350.
22. Li, E., C. Kunz-Jenkins, and S. L. Stanley, Jr. 1992. Isolation and characterization of genomic clones encoding a serine-rich Entamoeba histolytica protein. Mol. Biochem. Parasitol. 50:355-358.
23. McGowan, K., C. F. Deneke, G. M. Thorne, and S. L. Gorbach. 1982. Entamoeba histolytica cytotoxin: purification, characterization, strain virulence, and protease activity. J. Infect. Dis. 146:616-625.
24. Moody, S., S. Becker, Y. Nuchamowitz, and D. Mirelman. 1997. Virulent and avirulent Entamoeba histolytica and E. dispar differ in their cell surface phosphorylated glycolipids. Parasitology 114:95-104.
25. Ohnishi, K., and M. Murata. 1997. Present characteristic of symptomatic amebiasis due to Entamoeba histolytica in the east-southeast area of Tokyo. Epidemiol. Infect. 119:363-367.
26. Ouchterlony, O. 1966. The antigenic pattern of immunoglobulins. G. Mal. Infett. Parasit. 18(Suppl. 1):942-948.
27. Petri, W. A., Jr. 2002. Pathogenesis of amebiasis. Curr. Opin. Microbiol. 5:443-447.
28. Petri, W. A., Jr., R. Haque, D. Lyerly, and R. R. Vines. 2000. Estimating the impact of amebiasis on health. Parasitol. Today 16:320-321.
29. Robinson, G. L. 1968. Laboratory cultivation of some human parasitic amoebae. J. Gen. Microbiol. 53:69-79.
30. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. N.Y.
31. Stanley, S. L., Jr. 1997. Progress towards development of a vaccine for amebiasis. Clin. Microbiol. Rev. 10:637-649.
32. Stanley, S. L., Jr. 2001. Protective immunity to amebiais: new insights and new challenges. J. Infect. Dis. 184:504-506.
33. Stanley, S. L., Jr., and S. L. Reed. 2001. Microbes and microbial toxin: paradigms for microbial mucosal I interactions. VI. Entamoeba histolytica: parasite-host interactions. Am. J. Physiol. Gastrointest. Liver Physiol. 280: G1049-G1054.
34. Stanley, S. L., Jr., T. F. H. G. Jackson, S. L. Reed, J. Calderon, C. Kunz-Jenkins, V. Gathiram and E. Li. 1991. Serodiagnosis of invasive amebiasis using a recombinant Entamoeba histolytica protein. JAMA 266:1984-1986.
35. Stanley, S. L., Jr., A. Becker, C. Kunz-Jenkins, L. Foster, and E. Li. 1990. Cloning and expression of a membrane antigen of Entamoeba histolytica possessing multiple tandem repeats. Proc. Natl. Acad. Sci. USA 87:4976-4980.
36. Takeuchi, T., H. Matsuda, E. Okuzawa, T. Nozaki, S. Kobayashi, and H. Tanaka. 1988. Application of a micro enzyme-linked immunosorbent assay (ELISA) to detection of anti-amoebic antibody in various forms of amoebic infection. Jpn. J. Exp, Med. 58:229-232.
37. Takeuchi, T., Y. Miyahira, S. Kobayashi, T. Nozaki, S. R. Motta, and J. Matsuda. 1990. High seropositivity for Entamoeba histolytica infection in Japanese homosexual men: further evidence for the occurrence of pathogenic strains. Trans. R. Soc. Trop. Med. Hyg. 84:250-251.
38. Villagomez-Castro, J. C., and E. Lopez-Romero. 1996. Identification and partial characterization of three chitinase forms in Entamoeba invadens with emphasis on their inhibition by allosamidin. Antonie Leeuwenhoek 70:41-48.
39. Vinetz, J. M., J. G. Valenzuela, C. A. Specht, L. Aravind, R. C. Langer, J. M. Ribeiro, and D. C. Kaslow. 2000. Chitinases of the avian malaria parasite Plasmodium gallinaceum, a class of enzymes necessary for parasite invasion of the mosquito midgut. J. Biol. Chem. 275:10331-10341.
40. Weniger, B. G., Y. Takebe, C.-Y. Ou, and S. Yamazaki. 1994. The molecular epidemiology of HIV in Asia. AIDS 8(Suppl. 2:S13-S28.
41. WHO News and Activities. 1997. Entamoeba taxonomy. Bull. W. H. O. 75:291-292.
42. Willhoeft, U., and E. Tannich. 1999. The electrophoretic karyotype of Entamoeba histolytica. Mol. Biochem. Parasitol. 99:41-53.
43. Zaki, M., and C. G. Clark. 2001. Isolation and characterization of polymorphic DNA from Entamoeba histolytica. J. Clin. Microbiol. 39:897-905.
44. Zaki, M., P. Meelu, W. Sun, and C. G. Clark. 2002. Simultaneous differentiation and typing of Entamoeba histolytica and Entamoeba dispar. J. Clin. Microbiol. 40:1271-1276.
45. Zhang, T., and S. L. Stanley, Jr. 1999. DNA vaccination with the serine-rich Entamoeba histolytica protein (SREHP) prevents amebic liver abscess in rodent models of disease. Vaccine 18:868-874.
46. Zhang, T., P. R. Cieslak, L. Foster, C. Kunz-Jenkins, and S. L. Stanley, Jr. 1994. Antibody to the serine-rich Entamoeba histolytica protein (SREHP) prevents amebic liver abscess in severe combined immunodeficient (SCID) mice. Parasite Immunol. 16:225-230.